University of L'Aquila ^University

Recent work: Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia (TOSCA)

Technology: COVID Labs/Universities

Industry: COVID R&D

Headquarters: Italy

Founded Date: N/A

Employees Number: N/A

Funding Status: N/A

University of L'Aquila University